Why it was recalled
Failed Impurities/Degradation Specifications
Product description
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72
Lot numbers, UPCs & expiration codes
Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
Where it was sold
US Nationwide.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0300-2026
- Classification
- Class III
- Status
- Ongoing
- Recall initiated
- Dec 15, 2025
- FDA report date
- Feb 4, 2026
- Quantity
- N/A
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- NOVADOZ PHARMACEUTICALS LLC
Original FDA data
Every field from FDA enforcement report D-0300-2026, exactly as published.
Show all FDA fields
- City
- Piscataway
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 98156
- Address
- 20 Duke Rd Ste A
- Code information
- Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027
- Postal code
- 08854-3714
- Report date
- Feb 4, 2026
- Product type
- Drugs
- Recall number
- D-0300-2026
- Classification
- Class III
- Recalling firm
- NOVADOZ PHARMACEUTICALS LLC
- Reason for recall
- Failed Impurities/Degradation Specifications
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72
- Distribution pattern
- US Nationwide.
- Recall initiation date
- Dec 15, 2025
- Initial firm notification
- Letter
- Center classification date
- Jan 28, 2026